$0.0400
0.014758.1%
Last update: Oct 15, 8:58 AM
$0.0400
0.014758.1%
Ernexa Therapeutics Inc (ERNAW) Stock Price, Quote, News & History
ERNAWNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Ernexa Therapeutics Inc is a preclinical-stage synthetic allogeneic iMSC therapy company developing medicines to treat various forms of cancer and other diseases with high unmet medical needs. Its main product candidate, ERNA-101, capitalizes on the...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Ernexa Therapeutics (NASDAQ:ERNAW) through any online brokerage.
Other companies in Ernexa Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
There is no analysis for Ernexa Therapeutics to provide a consensus price target.
The stock price for Ernexa Therapeutics (NASDAQ: ERNAW) is $0.04 last updated October 15, 2026 at 8:58 AM EDT.
There are no upcoming dividends for Ernexa Therapeutics.
Ernexa Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Ernexa Therapeutics.
Ernexa Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
